HAE vs ITGR

For growth investors, Integer Holdings Corporation (ITGR) is the stronger pick with 7.

6% revenue growth year-over-year, versus 4. 0% for Haemonetics Corporation (HAE). Haemonetics Corporation (HAE) offers the better valuation at 15. 9x trailing P/E (10. 6x forward), making it the more compelling value choice. Analysts rate Haemonetics Corporation (HAE) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Haemonetics Corporation (HAE) is the cheapest at 15.

9x versus Integer Holdings Corporation at 29. 9x. On forward P/E, Haemonetics Corporation is actually cheaper at 10. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Haemonetics Corporation wins at 0. 61x versus Integer Holdings Corporation's 3. 02x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Integer Holdings Corporation (ITGR) delivered a total return of -8.

4%, compared to -14. 3% for Haemonetics Corporation (HAE). Over 10 years, the gap is even starker: ITGR returned +166. 2% versus HAE's +89. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Haemonetics Corporation (HAE) is the lower-risk stock at 0.

48β versus Integer Holdings Corporation's 0. 72β — meaning ITGR is approximately 51% more volatile than HAE relative to the S&P 500. On balance sheet safety, Integer Holdings Corporation (ITGR) carries a lower debt/equity ratio of 80% versus 149% for Haemonetics Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Integer Holdings Corporation (ITGR) is pulling ahead at 7.

6% versus 4. 0% for Haemonetics Corporation (HAE). On earnings-per-share growth, the picture is similar: Haemonetics Corporation grew EPS 44. 5% year-over-year, compared to -15. 0% for Integer Holdings Corporation. Over a 3-year CAGR, ITGR leads at 11. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Haemonetics Corporation (HAE) is the more profitable company, earning 12.

3% net margin versus 5. 6% for Integer Holdings Corporation — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HAE leads at 16. 3% versus 11. 3% for ITGR. At the gross margin level — before operating expenses — HAE leads at 57. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Haemonetics Corporation (HAE) is the more undervalued stock at a PEG of 0. 61x versus Integer Holdings Corporation's 3. 02x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Haemonetics Corporation (HAE) trades at 10. 6x forward P/E versus 13. 3x for Integer Holdings Corporation — 2. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HAE: 60. 7% to $84. 60.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Haemonetics Corporation (HAE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

48)). Both have compounded well over 10 years (HAE: +89. 4%, ITGR: +166. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HAE is a small-cap deep-value stock; ITGR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.